# Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review

> **NCT07307157** · — · ENROLLING_BY_INVITATION · sponsor: **Harvard Medical School (HMS and HSDM)** · enrollment: 30 (estimated)

## Conditions studied

- Brain Cancer
- Lung Cancer (Diagnosis)
- Renal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Digital Pathology Evaluation

## Key facts

- **NCT ID:** NCT07307157
- **Lead sponsor:** Harvard Medical School (HMS and HSDM)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-06-12
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07307157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07307157, "Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07307157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*